Ameritas Investment Partners’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,835
| Closed | -$152K | – | 3288 |
|
|
2024
Q1 | $152K | Buy |
3,835
+464
| +14% | +$18.4K | 0.01% | 1478 |
|
|
2023
Q4 | $64.3K | Buy |
3,371
+750
| +29% | +$14.3K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $30K | Hold |
2,621
| – | – | ﹤0.01% | 2352 |
|
|
2023
Q2 | $26.9K | Buy |
2,621
+721
| +38% | +$7.41K | ﹤0.01% | 2404 |
|
|
2023
Q1 | $14.7K | Buy |
1,900
+989
| +109% | +$7.64K | ﹤0.01% | 2572 |
|
|
2022
Q4 | $7.49K | Hold |
911
| – | – | ﹤0.01% | 2866 |
|
|
2022
Q3 | $6K | Hold |
911
| – | – | ﹤0.01% | 2909 |
|
|
2022
Q2 | $7K | Hold |
911
| – | – | ﹤0.01% | 2924 |
|
|
2022
Q1 | $8K | Hold |
911
| – | – | ﹤0.01% | 2870 |
|
|
2021
Q4 | $13K | Hold |
911
| – | – | ﹤0.01% | 2829 |
|
|
2021
Q3 | $10K | Hold |
911
| – | – | ﹤0.01% | 2949 |
|
|
2021
Q2 | $8K | Buy |
+911
| New | +$8K | ﹤0.01% | 2964 |
|